Medicamen Biotech Profit & Loss Annual

BSE: 531146 | NSE: MEDICAMEQ | ISIN: INE646B01010 | Sector: Biotechnology & Drugs

442.70 -5.35 (-1.19%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	179.31	140.87	115.45	112.72
Total Revenue	179.31	140.87	115.45	112.72
Costof Revenue Total	92.60	85.99	65.56	77.57
Gross Profit	86.71	54.88	49.89	35.15
Selling/ General/ Admin Expenses Total	30.07	21.82	17.58	11.30
Depreciation/ Amortization	7.09	6.37	5.77	2.52
Other Operating Expenses Total	34.40	9.06	8.64	4.50
Total Operating Expense	164.16	123.24	97.55	95.89
Operating Income	15.15	17.63	17.90	16.83
Interest Inc( Exp) Net- Non- Op Total	-43.97	-5.28	2.04	-1.75
Other Net	2.33	-0.05	0.00	-0.25
Net Income Before Taxes	13.08	17.05	18.09	16.39
Provisionfor Income Taxes	3.58	2.32	3.20	4.26
Net Income After Taxes	9.49	14.73	14.90	12.13
Minority Interest	1.44	0.12	-	-
Net Income Before Extra Items	10.93	14.84	14.90	12.13
Net Income	10.93	14.84	14.90	12.13
Income Availableto Com Excl Extra Ord	10.93	14.84	14.90	12.13
Income Availableto Com Incl Extra Ord	10.93	14.84	14.90	12.13
Diluted Net Income	10.93	14.84	14.90	12.13
Diluted Weighted Average Shares	1.46	1.25	1.22	1.22
Diluted EPS Excluding Extra Ord Items	7.50	11.92	12.19	9.93
DPS- Common Stock Primary Issue	1.00	1.00	1.00	1.00
Diluted Normalized EPS	7.50	11.92	12.19	9.93
Unusual Expense( Income)	-	0.00	-	-
Gain( Loss)on Saleof Assets	-	-0.07	0.00	-0.01